Literature DB >> 2016534

Cytokine gene expression in the islets of the diabetic Biobreeding/Worcester rat.

Z Jiang1, B A Woda.   

Abstract

The Biobreeding Worcester rat provides one of the best models of autoimmune diabetes. Immunopathologic studies of acute diabetes show that the islets are infiltrated by T cells and macrophages. It has been hypothesized that the islets are damaged by the secretion of cytokines such as IL-1 and TNF-alpha and that their function may be altered by IL-6. In this study, we utilized in situ hybridization to determine the expression of the IL-1, TNF, and IL-6 genes within the pancreas of the acute diabetic Biobreeding Worcester rat. These studies showed that cells expressing IL-1, TNF, and IL-6 were present within the islets and in the exocrine pancreas surrounding islets, ducts, and vessels and in an interstitial location. Cells expressing TNF and IL-1 mRNA were present in about 20% of the islets, whereas cells expressing IL-6 were present in about 4% of the islets. Islets containing TNF- or IL-1-positive cells contained about three positive cells per islet whereas only about one IL-6-positive cell was present per islet. In 26% of the islets peri-insular TNF-positive cells were found. Peri-insular IL-1 positive cells were seen in 14% of the islets and 8% showed peri-insular IL-6 positive cells. In nondiabetic 30-day old DP or 90-day-old DR rats intra-islet cytokine gene expression was not seen. Our studies support the view that cytokines are important in beta cell destruction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2016534

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Macrophages and dendritic cells infiltrating islets with or without beta cells produce tumour necrosis factor-alpha in patients with recent-onset type 1 diabetes.

Authors:  S Uno; A Imagawa; K Okita; K Sayama; M Moriwaki; H Iwahashi; K Yamagata; S Tamura; Y Matsuzawa; T Hanafusa; J Miyagawa; I Shimomura
Journal:  Diabetologia       Date:  2007-01-13       Impact factor: 10.122

2.  Interleukin-1 beta and GTP-binding proteins.

Authors:  A Sjöholm
Journal:  Diabetologia       Date:  1996-02       Impact factor: 10.122

Review 3.  The role of interleukin-1 in the pathogenesis of IDDM.

Authors:  T Mandrup-Poulsen
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

4.  Exposure of human islets to cytokines can result in disproportionately elevated proinsulin release.

Authors:  K Hostens; D Pavlovic; Y Zambre; Z Ling; C Van Schravendijk; D L Eizirik; D G Pipeleers
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

Review 5.  Aspects of novel sites of regulation of the insulin stimulus-secretion coupling in normal and diabetic pancreatic islets.

Authors:  A Sjöholm
Journal:  Endocrine       Date:  1998-08       Impact factor: 3.633

6.  Differential interleukin-1 receptor antagonism on pancreatic beta and alpha cells. Studies in rodent and human islets and in normal rats.

Authors:  U Zumsteg; J I Reimers; F Pociot; L Mørch; S Helqvist; M Brendel; R Alejandro; T Mandrup-Poulsen; C A Dinarello; J Nerup
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

7.  Quantitative phenotypic and functional analyses of islet immune cells before and after diabetes onset in the BB rat.

Authors:  N Hosszufalusi; E Chan; M Teruya; S Takei; G Granger; M A Charles
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

Review 8.  Interleukin-6 in autoimmune disease. Role of IL-6 in physiology and pathology of the immune defense.

Authors:  L Graeve; M Baumann; P C Heinrich
Journal:  Clin Investig       Date:  1993-08

9.  Role of infiltrating T cells for impaired glucose metabolism in pancreatic islets isolated from non-obese diabetic mice.

Authors:  E Strandell; S Sandler; C Boitard; D L Eizirik
Journal:  Diabetologia       Date:  1992-10       Impact factor: 10.122

Review 10.  On the pathogenesis of IDDM.

Authors:  J Nerup; T Mandrup-Poulsen; S Helqvist; H U Andersen; F Pociot; J I Reimers; B G Cuartero; A E Karlsen; U Bjerre; T Lorenzen
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.